JAMA Pediatrics - A new study @JAMAPediatrics reports that use of the antihistamine fexofenadine during pregnancy is not associated with poor fetal outcomes including birth defects, preterm birth, and stillbirth. https://ja.ma/2U0kStR #jamapediatrics #